메뉴 건너뛰기




Volumn 33, Issue 4, 2008, Pages 270-278

Aspirin "resistance"

Author keywords

Aspirin resistance; Cyclooxygenase; Platelet aggregation; Platelets; Thromboxane

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; CYCLOOXYGENASE 1; EPTIFIBATIDE; IBUPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; THROMBOXANE A2; TIROFIBAN;

EID: 46449105570     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-008-3129-x     Document Type: Review
Times cited : (17)

References (59)
  • 1
    • 0037065502 scopus 로고    scopus 로고
    • Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
    • Antithrombotic Trialists' Collaboration
    • Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.
    • (2002) BMJ , vol.324 , pp. 71-86
  • 2
    • 21244446907 scopus 로고    scopus 로고
    • Low-dose aspirin increases aspirin resistance in patients with coronary artery disease
    • Lee PY, Chen WH, Ng W, et al. Low-dose aspirin increases aspirin resistance in patients with coronary artery disease. Am J Med 2005;118:723-7.
    • (2005) Am J Med , vol.118 , pp. 723-727
    • Lee, P.Y.1    Chen, W.H.2    Ng, W.3
  • 3
    • 0141762320 scopus 로고    scopus 로고
    • Pharmacokinetic and pharmacodynamic differences between two low dosages of aspirin may affect therapeutic outcomes
    • Cerletti C, Dell'Elba G, Manarini S, et al. Pharmacokinetic and pharmacodynamic differences between two low dosages of aspirin may affect therapeutic outcomes. Clin Pharmacokinet 2003;42:1059-70.
    • (2003) Clin Pharmacokinet , vol.42 , pp. 1059-1070
    • Cerletti, C.1    Dell'Elba, G.2    Manarini, S.3
  • 4
    • 10744228434 scopus 로고    scopus 로고
    • Lack of aspirin effect: Aspirin resistance or resistance to taking aspirin?
    • Cotter G, Shemesh E, Zehavi M, et al. Lack of aspirin effect: aspirin resistance or resistance to taking aspirin? Am Heart J 2004;147:293-300.
    • (2004) Am Heart J , vol.147 , pp. 293-300
    • Cotter, G.1    Shemesh, E.2    Zehavi, M.3
  • 5
    • 16844362580 scopus 로고    scopus 로고
    • Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction
    • Schwartz KA, Schwartz DE, Ghosheh K, et al. Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction. Am J Cardiol 2005;95:973-5.
    • (2005) Am J Cardiol , vol.95 , pp. 973-975
    • Schwartz, K.A.1    Schwartz, D.E.2    Ghosheh, K.3
  • 6
    • 33750924102 scopus 로고    scopus 로고
    • A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease
    • Biondi-Zoccai GG, Lotrionte M, Agostoni P, et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease. Eur Heart J 2006;27:2667-74.
    • (2006) Eur Heart J , vol.27 , pp. 2667-2674
    • Biondi-Zoccai, G.G.1    Lotrionte, M.2    Agostoni, P.3
  • 7
    • 0029610453 scopus 로고
    • Variability in the pharmacokinetics and pharmacodynamics of low dose aspirin in healthy male volunteers
    • Benedek IH, Joshi AS, Pieniaszek HJ, et al. Variability in the pharmacokinetics and pharmacodynamics of low dose aspirin in healthy male volunteers. J Clin Pharmacol 1995;35:1181-6.
    • (1995) J Clin Pharmacol , vol.35 , pp. 1181-1186
    • Benedek, I.H.1    Joshi, A.S.2    Pieniaszek, H.J.3
  • 8
    • 33747168513 scopus 로고    scopus 로고
    • Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers
    • Cox D, Maree AO, Dooley M, et al. Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers. Stroke 2006;37:2153-8.
    • (2006) Stroke , vol.37 , pp. 2153-2158
    • Cox, D.1    Maree, A.O.2    Dooley, M.3
  • 9
    • 33745325634 scopus 로고    scopus 로고
    • Overcoming aspirin resistance: Increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease
    • Wong S, Morel-Kopp MC, Chen Q, et al. Overcoming aspirin resistance: increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease. Thromb Haemost 2006;95:1042-3.
    • (2006) Thromb Haemost , vol.95 , pp. 1042-1043
    • Wong, S.1    Morel-Kopp, M.C.2    Chen, Q.3
  • 10
    • 0035807799 scopus 로고    scopus 로고
    • A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirin
    • Ouellet M, Riendeau D, Percival MD. A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirin. Proc Natl Acad Sci U S A 2001;98:14583-8.
    • (2001) Proc Natl Acad Sci U S A , vol.98 , pp. 14583-14588
    • Ouellet, M.1    Riendeau, D.2    Percival, M.D.3
  • 11
    • 37549014900 scopus 로고    scopus 로고
    • Pyrazolinone analgesics prevent the antiplatelet effect of aspirin and preserve human platelet thromboxane synthesis
    • Hohlfeld T, Zimmermann N, Weber AA, et al. Pyrazolinone analgesics prevent the antiplatelet effect of aspirin and preserve human platelet thromboxane synthesis. J Thromb Haemost 2008;6:166-73.
    • (2008) J Thromb Haemost , vol.6 , pp. 166-173
    • Hohlfeld, T.1    Zimmermann, N.2    Weber, A.A.3
  • 12
    • 0035924765 scopus 로고    scopus 로고
    • Cyclooxygenase inhibitors and the antiplatelet effects of aspirin
    • Catella-Lawson F, Reilly MP, Kapoor SC, et al. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med 2001;345:1809-17.
    • (2001) N Engl J Med , vol.345 , pp. 1809-1817
    • Catella-Lawson, F.1    Reilly, M.P.2    Kapoor, S.C.3
  • 13
    • 17144407991 scopus 로고    scopus 로고
    • Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects
    • Capone ML, Sciulli MG, Tacconelli S, et al. Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects. J Am Coll Cardiol 2005;45:1295-301.
    • (2005) J Am Coll Cardiol , vol.45 , pp. 1295-1301
    • Capone, M.L.1    Sciulli, M.G.2    Tacconelli, S.3
  • 14
    • 0037180328 scopus 로고    scopus 로고
    • Reasons for resistance to aspirin in cardiovascular disease
    • Szczeklik A, Musial J, Undas A. Reasons for resistance to aspirin in cardiovascular disease. Circulation 2002;106:e181-2.
    • (2002) Circulation , vol.106
    • Szczeklik, A.1    Musial, J.2    Undas, A.3
  • 15
    • 0037431745 scopus 로고    scopus 로고
    • Platelet responsiveness to aspirin in patients with hyperlipidaemia
    • Friend M, Vucenik I, Miller M. Platelet responsiveness to aspirin in patients with hyperlipidaemia. BMJ 2003;326:82-3.
    • (2003) BMJ , vol.326 , pp. 82-83
    • Friend, M.1    Vucenik, I.2    Miller, M.3
  • 16
    • 0030754003 scopus 로고    scopus 로고
    • Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease
    • Davi G, Gresele P, Violi F, et al. Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease. Circulation 1997;96:69-75.
    • (1997) Circulation , vol.96 , pp. 69-75
    • Davi, G.1    Gresele, P.2    Violi, F.3
  • 17
    • 39049101880 scopus 로고    scopus 로고
    • Aspirin resistance and diabetes mellitus
    • Ajjan R, Storey RF, Grant PJ. Aspirin resistance and diabetes mellitus. Diabetologia 2008;51:385-90.
    • (2008) Diabetologia , vol.51 , pp. 385-390
    • Ajjan, R.1    Storey, R.F.2    Grant, P.J.3
  • 18
    • 0028828489 scopus 로고
    • Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin
    • Hung J, Lam JY, Lacoste L, et al. Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin. Circulation 1995;92:2432-6.
    • (1995) Circulation , vol.92 , pp. 2432-2436
    • Hung, J.1    Lam, J.Y.2    Lacoste, L.3
  • 19
    • 0037454168 scopus 로고    scopus 로고
    • A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease
    • Gum PA, Kottke-Marchant K, Welsh PA, et al. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 2003;41:961-5.
    • (2003) J Am Coll Cardiol , vol.41 , pp. 961-965
    • Gum, P.A.1    Kottke-Marchant, K.2    Welsh, P.A.3
  • 20
    • 0035894645 scopus 로고    scopus 로고
    • Epinephrine - via activation of p38-MAPK - abolishes the effect of aspirin on platelet deposition to collagen
    • Mustonen P, van Willigen G, Lassila R. Epinephrine - via activation of p38-MAPK - abolishes the effect of aspirin on platelet deposition to collagen. Thromb Res 2001;104:439-49.
    • (2001) Thromb Res , vol.104 , pp. 439-449
    • Mustonen, P.1    van Willigen, G.2    Lassila, R.3
  • 21
    • 0028288681 scopus 로고
    • Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin
    • Larsson PT, Wallen NH, Hjemdahl P. Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin. Circulation 1994;89:1951-7.
    • (1994) Circulation , vol.89 , pp. 1951-1957
    • Larsson, P.T.1    Wallen, N.H.2    Hjemdahl, P.3
  • 22
    • 0034283498 scopus 로고    scopus 로고
    • Increased platelet aggregability during exercise in patients with previous myocardial infarction. Lack of inhibition by aspirin
    • Hurlen M, Seljeflot I, Arnesen H. Increased platelet aggregability during exercise in patients with previous myocardial infarction. Lack of inhibition by aspirin. Thromb Res 2000;99:487-94.
    • (2000) Thromb Res , vol.99 , pp. 487-494
    • Hurlen, M.1    Seljeflot, I.2    Arnesen, H.3
  • 23
    • 34247574729 scopus 로고    scopus 로고
    • Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin
    • Guthikonda S, Lev EI, Patel R, et al. Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin. J Thromb Haemost 2007;5:490-6.
    • (2007) J Thromb Haemost , vol.5 , pp. 490-496
    • Guthikonda, S.1    Lev, E.I.2    Patel, R.3
  • 24
  • 25
    • 0345040152 scopus 로고    scopus 로고
    • Cyclooxygenase-2 in human platelets as a possible factor in aspirin resistance
    • Weber A-A, Zimmermann K, Meyer-Kirchrath J, et al. Cyclooxygenase-2 in human platelets as a possible factor in aspirin resistance. Lancet 1999;353:900.
    • (1999) Lancet , vol.353 , pp. 900
    • Weber, A.-A.1    Zimmermann, K.2    Meyer-Kirchrath, J.3
  • 26
    • 0034730075 scopus 로고    scopus 로고
    • Oxidant stress and aspirin-insensitive thromboxane biosynthesis in severe unstable angina
    • Cipollone F, Ciabattoni G, Patrignani P, et al. Oxidant stress and aspirin-insensitive thromboxane biosynthesis in severe unstable angina. Circulation 2000;102:1007-13.
    • (2000) Circulation , vol.102 , pp. 1007-1013
    • Cipollone, F.1    Ciabattoni, G.2    Patrignani, P.3
  • 27
    • 18444377050 scopus 로고    scopus 로고
    • Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets
    • Rocca B, Secchiero P, Ciabattoni G, et al. Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets. Proc Natl Acad Sci U S A 2002;99:7634-9.
    • (2002) Proc Natl Acad Sci U S A , vol.99 , pp. 7634-7639
    • Rocca, B.1    Secchiero, P.2    Ciabattoni, G.3
  • 28
    • 0037101578 scopus 로고    scopus 로고
    • Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate
    • Macchi L, Christiaens L, Brabant S, et al. Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate. Thromb Res 2002;107:45-9.
    • (2002) Thromb Res , vol.107 , pp. 45-49
    • Macchi, L.1    Christiaens, L.2    Brabant, S.3
  • 29
    • 0037107263 scopus 로고    scopus 로고
    • Enhanced platelet aggregation with TRAP-6 and collagen in platelet aggregometry in patients with venous thromboembolism
    • Weber M, Gerdsen F, Gutensohn K, et al. Enhanced platelet aggregation with TRAP-6 and collagen in platelet aggregometry in patients with venous thromboembolism. Thromb Res 2002;107:325-8.
    • (2002) Thromb Res , vol.107 , pp. 325-328
    • Weber, M.1    Gerdsen, F.2    Gutensohn, K.3
  • 30
    • 0036183757 scopus 로고    scopus 로고
    • Towards a definition of aspirin resistance: A typological approach
    • Weber A-A, Przytulski B, Schanz A, et al. Towards a definition of aspirin resistance: a typological approach. Platelets 2002;13:37-40.
    • (2002) Platelets , vol.13 , pp. 37-40
    • Weber, A.-A.1    Przytulski, B.2    Schanz, A.3
  • 31
    • 0035954288 scopus 로고    scopus 로고
    • Genetic and environmental contributions to platelet aggregation: The Framingham Heart Study
    • O'Donnell CJ, Larson MG, Feng D, et al. Genetic and environmental contributions to platelet aggregation: the Framingham Heart Study. Circulation 2001;103:3051-6.
    • (2001) Circulation , vol.103 , pp. 3051-3056
    • O'Donnell, C.J.1    Larson, M.G.2    Feng, D.3
  • 32
    • 0037256309 scopus 로고    scopus 로고
    • Genetic variation in cyclooxygenase 1: Effects on response to aspirin
    • Halushka MK, Walker LP, Halushka PV. Genetic variation in cyclooxygenase 1: effects on response to aspirin. Clin Pharmacol Ther 2003;73:122-30.
    • (2003) Clin Pharmacol Ther , vol.73 , pp. 122-130
    • Halushka, M.K.1    Walker, L.P.2    Halushka, P.V.3
  • 33
    • 28444484957 scopus 로고    scopus 로고
    • Cyclooxygenase-1 haplotype modulates platelet response to aspirin
    • Maree AO, Curtin RJ, Chubb A, et al. Cyclooxygenase-1 haplotype modulates platelet response to aspirin. J Thromb Haemost 2005;3:2340-5.
    • (2005) J Thromb Haemost , vol.3 , pp. 2340-2345
    • Maree, A.O.1    Curtin, R.J.2    Chubb, A.3
  • 34
    • 33646079610 scopus 로고    scopus 로고
    • High glucose contributes to aspirin insensitivity in streptozotocin-diabetic rats: A multiparametric aggregation study
    • Watala C, Ulicna O, Golanski J, et al. High glucose contributes to aspirin insensitivity in streptozotocin-diabetic rats: a multiparametric aggregation study. Blood Coagul Fibrinolysis 2006;17:113-24.
    • (2006) Blood Coagul Fibrinolysis , vol.17 , pp. 113-124
    • Watala, C.1    Ulicna, O.2    Golanski, J.3
  • 35
    • 0042735242 scopus 로고    scopus 로고
    • Resistance in vitro to low-dose aspirin is associated with platelet PlA1 (GP IIIa) polymorphism but not with C807T (GP Ia/IIa) and C-5T Kozak (GP Ibalpha) polymorphisms
    • Macchi L, Christiaens L, Brabant S, et al. Resistance in vitro to low-dose aspirin is associated with platelet PlA1 (GP IIIa) polymorphism but not with C807T (GP Ia/IIa) and C-5T Kozak (GP Ibalpha) polymorphisms. J Am Coll Cardiol 2003;42:1115-9.
    • (2003) J Am Coll Cardiol , vol.42 , pp. 1115-1119
    • Macchi, L.1    Christiaens, L.2    Brabant, S.3
  • 37
    • 11144232964 scopus 로고    scopus 로고
    • Dimorphism in the P2Y1 ADP receptor gene is associated with increased platelet activation response to ADP
    • Hetherington SL, Singh RK, Lodwick D, et al. Dimorphism in the P2Y1 ADP receptor gene is associated with increased platelet activation response to ADP. Arterioscler Thromb Vasc Biol 2005;25:252-7.
    • (2005) Arterioscler Thromb Vasc Biol , vol.25 , pp. 252-257
    • Hetherington, S.L.1    Singh, R.K.2    Lodwick, D.3
  • 38
    • 0346726095 scopus 로고    scopus 로고
    • Antiplatelet effect of aspirin in patients with cerebrovascular disease
    • Alberts MJ, Bergman DL, Molner E, et al. Antiplatelet effect of aspirin in patients with cerebrovascular disease. Stroke 2004;35:175-8.
    • (2004) Stroke , vol.35 , pp. 175-178
    • Alberts, M.J.1    Bergman, D.L.2    Molner, E.3
  • 39
    • 0032700388 scopus 로고    scopus 로고
    • Ex vivo response to aspirin differs in stroke patients with single or recurrent events: A pilot study
    • Chamorro A, Escolar G, Revilla M, et al. Ex vivo response to aspirin differs in stroke patients with single or recurrent events: a pilot study. J Neurol Sci 1999;171:110-4.
    • (1999) J Neurol Sci , vol.171 , pp. 110-114
    • Chamorro, A.1    Escolar, G.2    Revilla, M.3
  • 40
    • 0037276966 scopus 로고    scopus 로고
    • Aspirin non-responder status in patients with recurrent cerebral ischemic attacks
    • Grundmann K, Jaschonek K, Kleine B, et al. Aspirin non-responder status in patients with recurrent cerebral ischemic attacks. J Neurol 2003;250:63-6.
    • (2003) J Neurol , vol.250 , pp. 63-66
    • Grundmann, K.1    Jaschonek, K.2    Kleine, B.3
  • 41
    • 38949119325 scopus 로고    scopus 로고
    • Aspirin "resistance" and risk of cardiovascular morbidity: Systematic review and meta-analysis
    • Krasopoulos G, Brister SJ, Beattie WS, et al. Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis. BMJ 2008;336:195-8.
    • (2008) BMJ , vol.336 , pp. 195-198
    • Krasopoulos, G.1    Brister, S.J.2    Beattie, W.S.3
  • 42
    • 34250816849 scopus 로고    scopus 로고
    • Aspirin resistance and adverse clinical events in patients with coronary artery disease
    • Chen WH, Cheng X, Lee PY, et al. Aspirin resistance and adverse clinical events in patients with coronary artery disease. Am J Med 2007;120:631-5.
    • (2007) Am J Med , vol.120 , pp. 631-635
    • Chen, W.H.1    Cheng, X.2    Lee, P.Y.3
  • 43
    • 29344466941 scopus 로고    scopus 로고
    • Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: The role of dual drug resistance
    • Lev EI, Patel RT, Maresh KJ, et al. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance. J Am Coll Cardiol 2006;47:27-33.
    • (2006) J Am Coll Cardiol , vol.47 , pp. 27-33
    • Lev, E.I.1    Patel, R.T.2    Maresh, K.J.3
  • 44
    • 1542708471 scopus 로고    scopus 로고
    • Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment
    • Chen WH, Lee PY, Ng W, et al. Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment. J Am Coll Cardiol 2004;43:1122-6.
    • (2004) J Am Coll Cardiol , vol.43 , pp. 1122-1126
    • Chen, W.H.1    Lee, P.Y.2    Ng, W.3
  • 45
    • 20344408497 scopus 로고    scopus 로고
    • Stent thrombosis is associated with an impaired response to antiplatelet therapy
    • Wenaweser P, Dorffler-Melly J, Imboden K, et al. Stent thrombosis is associated with an impaired response to antiplatelet therapy. J Am Coll Cardiol 2005;45:1748-52.
    • (2005) J Am Coll Cardiol , vol.45 , pp. 1748-1752
    • Wenaweser, P.1    Dorffler-Melly, J.2    Imboden, K.3
  • 46
    • 33645982865 scopus 로고    scopus 로고
    • High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome
    • Cuisset T, Frere C, Quilici J, et al. High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome. J Thromb Haemost 2006;4:542-9.
    • (2006) J Thromb Haemost , vol.4 , pp. 542-549
    • Cuisset, T.1    Frere, C.2    Quilici, J.3
  • 47
    • 46449107704 scopus 로고    scopus 로고
    • Zimmermann N, Gams E, Winter J, et al. Insufficient inhibition of platelets by aspirin after coronary artery bypass surgery. Circulation 2000;102:II-428.abstract.
    • Zimmermann N, Gams E, Winter J, et al. Insufficient inhibition of platelets by aspirin after coronary artery bypass surgery. Circulation 2000;102:II-428.abstract.
  • 48
    • 9644255792 scopus 로고    scopus 로고
    • Late saphenous vein graft occlusion in patients with coronary bypass: Possible role of aspirin resistance
    • Yilmaz MB, Balbay Y, Caldir V, et al. Late saphenous vein graft occlusion in patients with coronary bypass: possible role of aspirin resistance. Thromb Res 2005;115:25-9.
    • (2005) Thromb Res , vol.115 , pp. 25-29
    • Yilmaz, M.B.1    Balbay, Y.2    Caldir, V.3
  • 49
    • 30044450866 scopus 로고    scopus 로고
    • Endothelial injury and acquired aspirin resistance as promoters of regional thrombin formation and early vein graft failure after coronary artery bypass grafting
    • Poston RS, Gu J, Brown JM, et al. Endothelial injury and acquired aspirin resistance as promoters of regional thrombin formation and early vein graft failure after coronary artery bypass grafting. J Thorac Cardiovasc Surg 2006;131:122-30.
    • (2006) J Thorac Cardiovasc Surg , vol.131 , pp. 122-130
    • Poston, R.S.1    Gu, J.2    Brown, J.M.3
  • 50
    • 32844467799 scopus 로고    scopus 로고
    • New modalities and aspects of antiplatelet therapy for stroke prevention
    • Uchiyama S, Nakamura T, Yamazaki M, et al. New modalities and aspects of antiplatelet therapy for stroke prevention. Cerebrovasc Dis 2006;21:Suppl 1:7-16.
    • (2006) Cerebrovasc Dis , vol.21 , Issue.SUPPL. 1 , pp. 7-16
    • Uchiyama, S.1    Nakamura, T.2    Yamazaki, M.3
  • 51
    • 34347404722 scopus 로고    scopus 로고
    • Variable platelet response to aspirin in patients with ischemic stroke
    • Hohlfeld T, Weber A-A, Junghans U, et al. Variable platelet response to aspirin in patients with ischemic stroke. Cerebrovasc Dis 2007;24:43-50.
    • (2007) Cerebrovasc Dis , vol.24 , pp. 43-50
    • Hohlfeld, T.1    Weber, A.-A.2    Junghans, U.3
  • 52
    • 0027279350 scopus 로고
    • Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients
    • Grotemeyer KH, Scharafinski HW, Husstedt IW. Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients. Thromb Res 1993;71:397-403.
    • (1993) Thromb Res , vol.71 , pp. 397-403
    • Grotemeyer, K.H.1    Scharafinski, H.W.2    Husstedt, I.W.3
  • 53
    • 9844224482 scopus 로고    scopus 로고
    • Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty
    • Mueller MR, Salat A, Stangl P, et al. Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty. Thromb Haemost 1997;78:1003-7.
    • (1997) Thromb Haemost , vol.78 , pp. 1003-1007
    • Mueller, M.R.1    Salat, A.2    Stangl, P.3
  • 54
    • 0034976798 scopus 로고    scopus 로고
    • Individual dosing of ASA prophylaxis by controlling platelet aggregation
    • Syrbe G, Redlich H, Ludwig J, et al. Individual dosing of ASA prophylaxis by controlling platelet aggregation. Clin Appl Thromb Haemost 2001;7:209-13.
    • (2001) Clin Appl Thromb Haemost , vol.7 , pp. 209-213
    • Syrbe, G.1    Redlich, H.2    Ludwig, J.3
  • 55
    • 34547772153 scopus 로고    scopus 로고
    • Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology
    • Bassand JP, Hamm CW, Ardissino D, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology. Eur Heart J 2007;28:1598-660.
    • (2007) Eur Heart J , vol.28 , pp. 1598-1660
    • Bassand, J.P.1    Hamm, C.W.2    Ardissino, D.3
  • 56
    • 20144373281 scopus 로고    scopus 로고
    • Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation
    • Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 2005;352:1179-89.
    • (2005) N Engl J Med , vol.352 , pp. 1179-1189
    • Sabatine, M.S.1    Cannon, C.P.2    Gibson, C.M.3
  • 57
    • 0037145863 scopus 로고    scopus 로고
    • Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial
    • Steinhubl SR, Berger PB, Mann JT III, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002;288:2411-20.
    • (2002) JAMA , vol.288 , pp. 2411-2420
    • Steinhubl, S.R.1    Berger, P.B.2    Mann III, J.T.3
  • 58
    • 29244439006 scopus 로고    scopus 로고
    • Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: A randomized crossover trial
    • Eikelboom JW, Hankey GJ, Thom J, et al. Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial. J Thromb Haemost 2005;3:2649-55.
    • (2005) J Thromb Haemost , vol.3 , pp. 2649-2655
    • Eikelboom, J.W.1    Hankey, G.J.2    Thom, J.3
  • 59
    • 33750632582 scopus 로고    scopus 로고
    • Aspirin resistance or variable response or both?
    • Cheng X, Chen WH, Simon DI. Aspirin resistance or variable response or both? Am J Cardiol 2006;98:Suppl 1:S11-S7.
    • (2006) Am J Cardiol , vol.98 , Issue.SUPPL. 1
    • Cheng, X.1    Chen, W.H.2    Simon, D.I.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.